Opinion
Video
Author(s):
Research highlights the significant benefits of achieving ultra-low PSA levels in metastatic hormone-sensitive prostate cancer, delaying disease progression effectively.
Rationale for Ultra-Low PSA Threshold Analysis
Key Themes:
Expert Insights:
The discussion highlighted the historical relevance of low PSA levels in predicting treatment outcomes and the potential increased sensitivity of this threshold.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.